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Summary Twelve mineral oils, originating from naphthenic and paraffinic stocks and variously refined, were
evaluated for their potential to induce cutaneous neoplasia in female CF1 mice. The oils were applied to the
shorn dorsal skin for up to 78 weeks, using several different treatment regimes.
The sole acid/earth refined naphthenic spindle oil was a moderately potent cutaneous carcinogen. By
comparison, the 11 oils, processed by other refining routes, were less carcinogenic or non-carcinogenic to
murine skin. Two of the 11 oils were weak cutaneous carcinogens viz, a naphthenic spindle oil refined only by
mild hydrotreatment and a paraffinic spindle oil refined by mild solvent extraction and 'Ferrofining'. All 9
remaining oils had been solvent-extracted as part of the secondary refining process; none induced malignant
tumours, although solitary benign tumours of the treated site were recorded after exposure to 3 oils.
The cutaneous carcinogenic potential of the test oils did not correlate well with their potential to induce
epidermal hyperplasia at the treated site. Consequently, hyperplasia caused after short term exposure is of
little value for distinguishing between carcinogenic and non-carcinogenic oils.
An association between exposure to mineral oils
and the development of occupational cutaneous
cancer in man was reported by Leitch (1924).
Subsequently, mineral oils used as
coolants/lubricants in metal working operations
were implicated as the cause of scrotal cancer
among machine operators (Cruickshank & Squire,
1950). Evidence that occupational exposure to
mineral oils increases the risk of cutaneous cancer
induction is now substantial (Mastromatteo, 1955;
Cook et al., 1958; Fife, 1962; Roe et al., 1967;
Medical Research Council, 1968).
In 1965, Bingham et al. demonstrated that the
processing route used during refining influenced the
carcinogenic potential of mineral oils applied
topically to C3H/HeJ mice. Oils refined by the
acid/earth process were carcinogenic; in contrast,
none of the fully solvent refined oils induced
carcinomata.
The present work was initiated to investigate the
cutaneous carcinogenic potential of 12 mineral oils,
selected to be representative of those in use during
1970. The oils were derived from either naphthenic
or paraffinic stocks and subjected to various
refining processes.
Materials and methods
Animals
Specified pathogen-free female CFI mice bred in
Shell Toxicology Laboratory were used. This strain
has been shown to develop cutaneous tumours
following exposure to 3,4-benzo[a]pyrene in this
laboratory [Brown & Thorpe, personal
communication]. The mice, aged 6 weeks when
treatment was initiated, were housed singly in poly-
propylene cages, fed a nutritionally adequate rodent
diet (Diet 86S, supplied by Grain Harvesters,
Wingham, Kent) and provided with drinking water
ad libitum. The hair on the back of each mouse was
shorn with fine electric clippers before treatment
started and thereafter at weekly intervals as
required.
Oils
Twelve mineral oils were used; for reference
purposes, each oil was given the prefix N and
coded numerically. Details of the descriptions,
crude type, refining process(es) and physico-
chemical data for each oil are given in Tables I and
II and Figure 1.
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Experimental procedure
Prior to initiation of the long-term investigation, a
preliminary irritancy screen was carried out by
topical application of 0.25ml of each test oil to the
shorn backs of CF1 mice for 4 weeks using 3
different treatment regimes. On the basis of the
results obtained, treatment schedules for the long-
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Table I Description of mineral oils
CAS number
-assigned on basis
offeedstock and
Crude FINALprocessing
Oil Oil description type Processing route step (Note 2)
Ni Acid refined, pale Naphthenic Acid treatment/earth treat- CAS 64742-44-5*
spindle (Venezuela) ment.
N2 Hydrofined, pale Naphthenic Mild hydrotreatment CAS 64742-52-5*
spindle (Venezuela)
N3 100 solvent neutral; Paraffinic Solvent (liq. SO2/benzene) CAS 64742-65-0*
BG 20L extraction/"Ferrofining" (Note 5)
(Notes 1 and 3).
N4 100 solvent neutral; Paraffinic Solvent (furfural) extrac- CAS 64742-65-0*
BG 20S tion/"Ferrofining" (Note 5)
(Notes 1 and 4).
N6 600 solvent pale Naphthenic Solvent (furfural) extrac- CAS 64742-44-5*
(Venezuela) tion/earth treatment
N8 Adriatic spindle Paraffinic Solvent (furfural) extrac- CAS 64742-65-0*
(Venezuela) tion/solvent dewaxing
(Note 4).
N9 Medicinal grade Phenol extraction/oleum CAS 8042-47-5*
light liquid treatment/neutralization
paraffin, Grade 15 and clay treatment.
NIO 150 solvent pale Naphthenic Solvent extraction (liq. SO2)! CAS 64742-44-5*
(Venezuela) earth treatment.
Nl 1 Technical white oil Naphthenic Solvent extraction (liq. SO2)/ CAS 64742-53-6*
(Venezuela) hydrotreatment.
N12 60 solvent pale Naphthenic Solvent (liq. SO2) extraction/ CAS 64742-45-6*
(Venezuela) earth treatment.
N13 (Blend) Paraffinic Solvent (mild furfural) extrac- CAS 64742-65-0*
tion/solvent dewaxing
(Note 3).
N18 Medicinal grade heavy Naphthenic Solvent extraction/oleum CAS 8042-47-5*
liquid paraffin, treatment/neutralization
Grade 68 and clay treatment.
Notes 1. "Ferrofining" is a British Petroleum Co. patented hydrotreatment process.
2. Chemical Abstract Service (CAS) number as included in TSCA Inventory for oils manufactured by
different routes (except for N18). Processing step defining CAS number is italicized where
appropriate.
3. Viscosity Index (Table II) indicates "mild" extraction.
4. Viscosity Index (Table II) indicates "fully" extracted.
5. Oils assumed to have been finally dewaxed.
term (78 week) investigation were determined; the
most severe treatment regime for each oil was that
compatible both with histological epidermal
integrity and with lack of debilitating systemic
toxicity. The results of the preliminary screen
indicated that 6 of the 12 oils were well tolerated;
in the main study, these oils were applied undiluted
once or twice weekly. The other 6 oils were poorly
tolerated; in the main study, these oils were applied
undiluted once or twice weekly and a third
treatment regime was also used, viz. twice weekly
application of a 1:1 v/v dilution of these oils with
medicinal grade liquid paraffin (N18). Fifty mice
were randomly allocated to the control and each of
the treatment groups.
After the long-term investigation had been in
progress for 22 weeks, exposure to 7 of the oils had
resulted in severe hyperaemia and ulceration of the
shoulders, neck and face in some of the mice; these
lesions were a consequence of persistent scratchingMINERAL OILS-CUTANEOUS CARCINOGENIC POTENTIAL
Table II Characteristic bulk properties of mineral oils
Kinematic viscosity,
cSt, at: Pour Density Refractive Aromatic Sulphur
Viscosity point dU4 ASTM index at Carbon con- content,
400C 1000C index °C gml-1 colour 250C tent, % CA %W
Oil ASTM D 445* ASTM D 2270 ASTM D 97 LP. 190t ASTM D 1500 ASTM D 1747 See Note 1 See Note 2
Ni 19.66 3.41 Minus 11 -39 0.9228 4.5 1.5119 20 1.92
N2 19.76 3.50 8 -39 0.9046 L 1.5 1.4994 16 0.42
N3 19.09 3.84 85 -12 0.8770 L 1.0 1.4857 11 1.23
N4 19.38 3.95 96 -12 0.8685 L 2.0 1.4792 7 1.20
N6 121.2 10.10 44 -24 0.9016 2.0 1.4936 7 0.94
N8 20.10 4.05 98 -9 0.8576 L 1.5 1.4726 5 0.65
N9 13.99 3.20 86 -30 0.8487 0.0 1.4657 <0.3 0.016
N1O 32.07 4.80 46 -33 0.8794 L 0.5 1.4806 3 0.33
NIl 13.45 2.93 45 -48 0.8670 0.0 1.4733 2 0.05
N12 8.80 2.28 73 -57 0.8631 L 0.5 1.4709 1 0.13
N13 19.01 3.83 85 -12 0.8647 L 1.0 1.4767 6 0.74
N18 66.73 7.48 62 -33 0.8842 0.0 1.4813 <0.3 0.0002
Test Methods
*American Society for Testing Materials, Series D.
tlnstitute of Petroleum.
Note 1-Couperus, P.A., to be published.
Note 2-Van Grondelle et al., 1978.
Analyses carried out by A.v.d. Wiel, B.C. Ernsting and P.A. Couperus, of Koninklijke/Shell Laboratorium, Amsterdam, Netherlands.
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Figure 1 Major manufacturing procedures (simplified).
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in response to the pruritogenic properties of the
oils. These self-inflicted secondary lesions were
nearly always associated with evidence of primary
irritation of the dorsal treated site. Severely affected
animals were killed for humane reasons and the
initial treatment schedules were then modified for
the surviving animals. Treatment regimes are
summarized in Table III.
Each oil was applied to the shorn dorsal skin
using an all glass 1 ml syringe; for the first 22 weeks
of treatment, 0.25ml of oil was dispensed at each
application; thereafter, the volume was reduced to
0.2ml.
Clinical observations
The mice were observed daily and records were
kept of all clinical signs. The size, appearance and
site of all nodular and ulcerative cutaneous lesions
were documented weekly. The clinical criterion used
to define a cutaneous tumour was the development
of a 2mm nodule that persisted for 2 weeks. All
cutaneous nodules present at necropsy were
examined histologically. Some nodules sloughed
spontaneously and no histological examination of
these lesions was possible. For statistical purposes,
sloughed nodules were classified as papillomata if
they had attained a diameter of 2mm and had
persisted for 2 weeks.
Pathology
At the end of the 78-week period, all surviving mice
were killed by an i.p. injection of sodium
pentobarbitone. Necropsies were carried out on all
animals killed at the end of the study and on mice
killed or dying during the study, except in cases of
advanced autolysis. All macroscopic lesions were
recorded and the following tissues were removed
and fixed in 10% neutral formalin: skin from the
treated site, all cutaneous nodules and lungs. All
samples of skin and cutaneous nodules were
processed to 5 im paraffin wax sections and stained
with haematoxylin and eosin; histological
examination of these tissues was undertaken to
identify neoplastic lesions and to assess the severity
of epidermal hyperplasia at the site of treatment.
The lungs of all mice with cutaneous tumours were
examined histologically for the presence of
metastases.
Irritation at treated site
The degree of epidermal acanthosis, assessed
histologically, was used as a measure of irritancy.
The epidermal thickness was expressed as the mean
number of nucleated cell layers counted at 10
interfollicular sites along a stained sagittal section
of skin prepared from the treated back. The mean
number of nucleated cell layers was designated the
irritancy value. Mean irritancy values from 25 mice
in each treatment group were averaged. The means
were grouped according to the survival time of
individual animals, viz. 0-20 weeks, 21-40 weeks,
41-60 weeks and 61-78 weeks. By comparing the
irritancy values of the treated groups with those of
the controls, an assessment was made of the period
during which irritancy was initiated and of the
persistence ofirritation.
Statistical analysis
The risk of developing a skin tumour of 2mm
diameter was assessed by relating the actual
incidence to the expected incidence for each
treatment group compared with the untreated
controls. The significance of any effect was assessed
by a statistic distributed as x2 (Peto, 1974).
Lifetable values were calculated expressing variation
of risk with time for those oils where one or more
treatment regimes had induced a tumour incidence
of >2%.
Results
Survival
Survival was significantly reduced after exposure,
by one or more of the treatment regimes, to all but
two of the oils (N6, N18) compared with the
untreated controls. For humane reasons animals
were removed from the study because of extensive
ulceration of the head, neck and shoulders induced
by persistent scratching. Cutaneous ulceration,
often associated with dehydration and secondary
infection, was the major cause of death or terminal
illness of 80% of the decedents. Chronic renal
disease and systemic neoplasia, unrelated to
treatment, were other major causes of death in both
control and treated groups.
Cutaneous neoplasia oftreated site
Cutaneous tumours of the dorsal treated skin
developed after application of 6 of the 12 oils, viz.
NI, N2, N3, N4, NIO and N12 (Table IV). No
animal developed more than one tumour; of the 35
tumours that attained a diameter of 2mm and
persisted for at least 2 weeks, 9 sloughed
spontaneously.
All but one of the tumours identified
histologically were of epithelial origin (papilloma,
squamous cell carcinoma or sebaceous adenoma);
one dermal fibrosarcoma was also identified. There
were no pulmonary metastases of cutaneous
tumours.MINERAL OILS-CUTANEOUS CARCINOGENIC POTENTIAL 433
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Figure 2 Lifetable in respect of 2mm diameter cutaneous tumours.
There was a statistically significant increase in the
risk of developing cutaneous tumours following
exposure to the acid/earth refined oil N1 by all
treatment regimes, and to the solvent
extracted/"Ferrofined" oil N3 by one treatment
regime. Exposure to the other oils did not
significantly increase the incidence of cutaneous
tumours at the treated site compared with the
untreated controls. For 3 oils NI, N2 and N3,
where one or more treatment regimes had induced
a tumour incidence of more than 2%, the results
are displayed as a lifetable for 2mm diameter
tumours (Figure 2).
Cutaneous neoplasia distantfrom the treated site
Five tumours of cutaneous or s.c. origin were
identified in mice from 4 different groups, viz.
sebaceous adenoma of the nares (untreated
control), squamous cell carcinoma of the neck and
a dermal fibrosarcoma of the shoulder (N8),
squamous cell carcinoma of the orbit (N12) and a
basal cell carcinoma of the ventral abdomen (N13).
Cutaneous irritancy
The epidermis of untreated control mice was on
average 1.5-1.9 cells thick. The oils N6 and N18
were non-irritant, inducing no epidermal
hyperplasia after any of the treatment regimes used.
The remaining 10 oils induced a significant
increase in epidermal thickness (>2.0 cells thick)
compared with controls, after use of at least one of
the treatment regimes. The increase in thickness
either persisted throughout the 78-week exposure
period or was only seen in mice killed before the
end of the study, being absent in those killed
terminally. In some cases, the lower evidence of
irritancy at the end of the study was a consequence
of reduced exposure after 22 weeks' treatment.
Discussion
Bingham et al. (1965) reported that the refining
process route influenced the carcinogenic potential
of mineral oils, assessed by topical application to
murine skin. Acid/earth refined oils induced
cutaneous neoplasia; in contrast, none of the
solvent refined test oils was carcinogenic. The
authors suggested that solvent refining was more
effective in removing polycyclic aromatic
compounds from oils than acid/earth treatment.
These findings of Bingham et al. (1965) are
supported by the current work on the effect of
refining processes on the carcinogenic potential of
12 mineral oils, representative of industrial
lubricants available in 1970.
The products of refined petroleum oils have a
lower percentage aromatic carbon content (%CA)
that unrefined petroleum distillates. The %CA of a
refinery stream can be used as an indicator of the
severity of a refining process. The 12 test oils in this
study were manufactured from either naphthenic
crude (Venezuelan) or paraffinic crude oil (Middle
East) by different refining procedures.
Of the oils derived from naphthenic crude, the
least refined (Ni, 20% CA, acid/earth treatment)
was a cutaneous carcinogen for female CF1 mice.
Mild hydrotreatment resulted in a product (N2,
16% CA) with less carcinogenic activity than NI.
Rigorous refining processes, on the other hand,
using either sulphur dioxide or furfural extraction,
resulted in products with CA contents of 1-7%; of
these, each of 2 oils (N10, N12) induced a single
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benign cutaneous tumour at the treated site and 3
oils were non-carcinogenic to murine skin.
Similar results were obtained for those oils
manufactured from paraffinic crude. The least
refined oil of this group (N3, 11% CA) was a
product of mild sulphur dioxide and benzene
extraction followed by mild "Ferrofining"; this oil
was a weak cutaneous carcinogen, inducing
neoplasms at the treated site in 4 of 127 female
CFl mice. The other oils in this group had been
solvent-extracted with furfural; this more rigorous
treatment produced oils with % CA levels ranging
from 1-7%. One oil (N4) induced a solitary benign
tumour at the treated site; the remaining oils were
non-carcinogenic.
Since there is a low background incidence (0.2%)
of cutaneous tumours of the dorsal skin in the CF1
mice bred in this laboratory, identification of single
benign tumours in groups 100-127 treated mice
cannot be regarded as evidence of carcinogenic
activity.
Cutaneous irritation can be a problem in
cutaneous carcinogenicity studies. Despite the
preliminary study designed to establish dosing
regimes for the long-term investigation, the volume
(0.25ml), concentration and frequency of
application had to be changed during the course of
the study for several of the test oils. Primary
irritative dermatitis directly due to application of
the oils led in many cases to secondary self-inflicted
irritation due to scratching. As a consequence, the
treatment regimes for 6 of the oils were modified 22
weeks after the initiation ofthe study.
A correlation has previously been reported in
mice between the carcinogenic potential of
chemicals and their ability to increase the thickness
of the epidermis following short-term exposure
(Chouroulinkov et al., 1969). The correlation holds
for polycyclic aromatic compounds and may extent
to other classes of compounds, particularly if they
are lipid soluble (Lazar et al., 1963). In the present
study, epidermal hyperplasia, following short and
long-term exposure, was assessed histologically
from the number of viable epidermal cell layers in a
sagittal section of skin from the dorsal back. The 3
carcinogenic oils induced epidermal hyperplasia in
mice after both short and long-term exposure.
Other oils, proven non-carcinogenic in the long-
term study, also induced similar hyperplastic
changes in the epidermis. It was concluded,
therefore, that for oils, there is no correlation
between cutaneous carcinogenic potential and the
degree and duration of epidermal hyperplasia
induced by treatment.
The current work supports the concept that the
route of the refining process influences the
carcinogenic potential of oils. Mild acid/earth
refining processes are inadequate to reduce
substantially the carcinogenic potential of base oils.
In contrast, hydrotreatment or solvent extraction
methods can yield oils with no carcinogenic
potential.
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